Sign in

CIK 0001020214

  • Accelerated filer
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680262011
Phone
+1 925-288-6000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
  1. 4 Exercise or conversion Director acquired 12,758 shares (option exercise)
  2. 4 Open-market buy President and CEO bought 10,000 shares at $4.60 ($46,000)
  3. 4 Exercise or conversion President and CEO acquired 100 shares (option exercise)
  4. 4 Open-market sale Chief Financial Officer sold 2,786 shares at $6.51 ($18,138)
  5. 4/A Open-market sale SVP Reg. & Quality sold 10,886 shares at an average $6.01 ($65,428)
  6. 4/A Open-market sale Chief Legal Officer sold 10,783 shares at an average $6.01 ($64,762)
  7. 4/A Open-market sale President and CEO sold 45,459 shares at an average $6.00 ($272,708)
  8. 4/A Exercise or conversion Chief Scientific Officer acquired 29,334 shares (option exercise)
  9. 4 Open-market sale SVP Reg. & Quality sold 10,886 shares at an average $6.01 ($65,428)
  10. 4 Open-market sale Chief Legal Officer sold 10,783 shares at an average $6.01 ($64,762)
  11. 4 Open-market sale Chief Commercial Officer sold 5,979 shares at $5.90 ($35,274)
  12. 4 Open-market sale President and CEO sold 45,459 shares at an average $6.00 ($272,708)
  13. 4 Open-market sale Chief Financial Officer sold 7,690 shares at an average $6.26 ($48,128)
  14. 4 Exercise or conversion Chief Scientific Officer acquired 29,334 shares (option exercise)
  15. 4 Open-market sale Chief Medical Officer sold 9,890 shares at an average $5.96 ($58,977)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Financial Officer sold 2,783 shares at $5.86 ($16,313)
  19. 4 Open-market sale Chief Financial Officer sold 2,783 shares at $5.59 ($15,563)
  20. 4 Exercise or conversion President and CEO acquired 150,000 shares (option exercise)

Page 15 of 36 · 701 filings